These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28687760)

  • 21. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
    Paix A; Noel G; Falcoz PE; Levy P
    Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood?
    Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):64-71. PubMed ID: 16730447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interpreting survival data from clinical trials of surgery versus stereotactic body radiation therapy in operable Stage I non-small cell lung cancer patients.
    Samson P; Keogan K; Crabtree T; Colditz G; Broderick S; Puri V; Meyers B
    Lung Cancer; 2017 Jan; 103():6-10. PubMed ID: 28024698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8+ T-cell subsets defined by expression of CD45 isoforms differ in their capacity to produce IL-2, IFN-gamma and TNF-beta.
    Adamthwaite D; Cooley MA
    Immunology; 1994 Feb; 81(2):253-60. PubMed ID: 7908892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular immunity in hemodialysis patients: a quantitative analysis of immune cell subsets by flow cytometry.
    Deenitchina SS; Ando T; Okuda S; Kinukawa N; Hirakata H; Nagashima A; Fujishima M
    Am J Nephrol; 1995; 15(1):57-65. PubMed ID: 7872366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypofractionation regimens for stereotactic radiotherapy for large brain tumors.
    Yuan J; Wang JZ; Lo S; Grecula JC; Ammirati M; Montebello JF; Zhang H; Gupta N; Yuh WT; Mayr NA
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):390-7. PubMed ID: 18374501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial).
    Safi S; Beckhove P; Warth A; Benner A; Roeder F; Rieken S; Debus J; Dienemann H; Hoffmann H; Huber PE
    BMC Cancer; 2015 Dec; 15():988. PubMed ID: 26686362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC).
    Zimmermann FB; Geinitz H; Schill S; Thamm R; Nieder C; Schratzenstaller U; Molls M
    Acta Oncol; 2006; 45(7):796-801. PubMed ID: 16982542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunologic reconstitution of peripheral blood lymphocytes in patients treated by bone marrow transplantation].
    Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Otheo E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
    Med Clin (Barc); 1996 Feb; 106(5):169-73. PubMed ID: 8684015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cells.
    Adams PW; Lee HS; Waldman WJ; Sedmak DD; Morgan CJ; Ward JS; Orosz CG
    J Immunol; 1992 Jun; 148(12):3753-60. PubMed ID: 1351087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in systemic immune response after stereotactic ablative radiotherapy. Preliminary results of a prospective study in patients with early lung cancer.
    Rutkowski J; Ślebioda T; Kmieć Z; Zaucha R
    Pol Arch Intern Med; 2017 Apr; 127(4):245-253. PubMed ID: 28420863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results and prognostic factors of hypofractionated stereotactic radiation therapy for primary or metastatic lung cancer.
    Kim H; Ahn YC; Park HC; Lim DH; Nam H
    J Thorac Oncol; 2010 Apr; 5(4):526-32. PubMed ID: 20104193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors for occlusion of cerebral AVMs following radiation therapy : Radiation dose and prior embolization, but not Spetzler-Martin grade.
    Knippen S; Putz F; Semrau S; Lambrecht U; Knippen A; Buchfelder M; Schlaffer S; Struffert T; Fietkau R
    Strahlenther Onkol; 2017 Mar; 193(3):185-191. PubMed ID: 27757503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linac-based radiosurgery or hypofractionated stereotactic radiotherapy in the treatment of large cerebral arteriovenous malformations.
    Zabel-du Bois A; Milker-Zabel S; Huber P; Schlegel W; Debus J
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1049-54. PubMed ID: 16376487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency.
    de Lollo C; de Moraes Vasconcelos D; da Silva Oliveira LM; de Oliveira Titz T; Carneiro-Sampaio M; Jacob CM; da Silva Duarte AJ; Sato MN
    J Transl Med; 2016 May; 14(1):138. PubMed ID: 27188997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.
    Laranjeira P; Pedrosa M; Pedreiro S; Gomes J; Martinho A; Antunes B; Ribeiro T; Santos F; Trindade H; Paiva A
    Stem Cell Res Ther; 2015 Jan; 6(1):3. PubMed ID: 25559824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancer.
    Takeda A; Sanuki N; Eriguchi T; Kaneko T; Morita S; Handa H; Aoki Y; Oku Y; Kunieda E
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):257-63. PubMed ID: 23570699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of intracellular cytokine staining and bacterial superantigen to document suppression of the adaptive immune system in injured patients.
    Murphy T; Paterson H; Rogers S; Mannick JA; Lederer JA
    Ann Surg; 2003 Sep; 238(3):401-10; discussion 410-1. PubMed ID: 14501506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
    Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
    J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.